Skip to main content
Premium Trial:

Request an Annual Quote

Cue Partners With J&J's Janssen Pharma on HIV Viral Load Assay

NEW YORK (GenomeWeb) – Cue, a San Diego-based developer of analyte detection technologies, is collaborating with Johnson & Johnson's Janssen Pharmaceuticals to develop a quantitative HIV viral load test for resource-poor settings.

Under the agreement, which was facilitated by Johnson & Johnson Innovation, the partners will work to develop an affordable, portable, easy-to-use, and internet-enabled HIV quantitative viral load test using Cue's Lab-In-A-Box molecular diagnostics platform.

The test will combine proprietary nucleic acid amplification technology with Cue's cartridge-based system for molecular detection, which it currently uses to offer consumers assays for vitamin D and testosterone levels, inflammation, fertility, and influenza infection for general health and wellness monitoring.

"We're excited to work with Janssen, a leader in the HIV field, to accelerate the development of the HIV quantitative viral load test on Cue's platform," CEO Ayub Khattak said in a statement. "Together we can make a big impact on this significant global health challenge by bringing simplicity, immediacy, and affordability to the field of HIV viral load testing in an unprecedented way."

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.